Greig R, Chan R, Lipworth B. Type 2 biomarkers and airway hyper-responsiveness disconnect in uncontrolled severe asthma patients taking benralizumab or dupilumab. Ann Allergy Asthma Immunol 2025 Jul 26:S1081-1206(25)00379.
PMID: 40721206